Interaction of synthetic sarafotoxin with rat vascular endothelin receptors. 1989

Y Hirata, and H Yoshimi, and F Marumo, and T X Watanabe, and S Kumagaye, and K Nakajima, and T Kimura, and S Sakakibara
Department of Medicine, Tokyo Medical and Dental University, Japan.

The effects of synthetic analogs of sarafotoxin (STX) S6b, a snake venom peptide with a high sequence homology to the endothelium-derived vasoconstrictor endothelin (ET), on ET receptor binding activity and cytosolic free Ca2+ concentration [( Ca2+]i) were studied in cultured rat vascular smooth muscle cells. Binding studies revealed that [Cys1-15, Cys3-11] STX competed with 125I-ET for the binding to its vascular receptors with lower affinity than that of ET, but was far more effective than [Cys1-11, Cys3-15]STX in inhibiting the binding. [Cys1-15, Cys3-11]STX had a less potent effect on increasing [Ca2+]i than ET, whereas [Cys1-11, Cys3-15]STX was inactive. These data suggest that there may exist heterogenous subpopulations of the vascular ET/STX receptors, and that the proper double cyclic structure of STX is essential for interacting with its putative receptors to induce the [Ca2+]i response.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D014662 Vasoconstrictor Agents Drugs used to cause constriction of the blood vessels. Vasoactive Agonist,Vasoactive Agonists,Vasoconstrictor,Vasoconstrictor Agent,Vasoconstrictor Drug,Vasopressor Agent,Vasopressor Agents,Vasoconstrictor Drugs,Vasoconstrictors,Agent, Vasoconstrictor,Agent, Vasopressor,Agents, Vasoconstrictor,Agents, Vasopressor,Agonist, Vasoactive,Agonists, Vasoactive,Drug, Vasoconstrictor,Drugs, Vasoconstrictor
D014757 Viper Venoms Venoms from SNAKES of the viperid family. They tend to be less toxic than elapid or hydrophid venoms and act mainly on the vascular system, interfering with coagulation and capillary membrane integrity and are highly cytotoxic. They contain large amounts of several enzymes, other factors, and some toxins. Russell Viper Venom,Russell Viper Venoms,Russell's Viper Venom,Russell's Viper Venoms,Viperidae Venoms,Cerastes Venom,Cerastes Venoms,Egyptian Sand Viper Venom,Viper Venom,Viperotoxin,Russells Viper Venom,Russells Viper Venoms,Venom, Cerastes,Venom, Russell Viper,Venom, Russell's Viper,Venom, Viper,Venoms, Cerastes,Venoms, Russell Viper,Venoms, Russell's Viper,Venoms, Viper,Venoms, Viperidae,Viper Venom, Russell,Viper Venom, Russell's,Viper Venoms, Russell,Viper Venoms, Russell's

Related Publications

Y Hirata, and H Yoshimi, and F Marumo, and T X Watanabe, and S Kumagaye, and K Nakajima, and T Kimura, and S Sakakibara
August 1989, Biochemical and biophysical research communications,
Y Hirata, and H Yoshimi, and F Marumo, and T X Watanabe, and S Kumagaye, and K Nakajima, and T Kimura, and S Sakakibara
September 1989, Biochemical and biophysical research communications,
Y Hirata, and H Yoshimi, and F Marumo, and T X Watanabe, and S Kumagaye, and K Nakajima, and T Kimura, and S Sakakibara
October 1989, European journal of pharmacology,
Y Hirata, and H Yoshimi, and F Marumo, and T X Watanabe, and S Kumagaye, and K Nakajima, and T Kimura, and S Sakakibara
January 1990, Life sciences,
Y Hirata, and H Yoshimi, and F Marumo, and T X Watanabe, and S Kumagaye, and K Nakajima, and T Kimura, and S Sakakibara
March 1992, British journal of pharmacology,
Y Hirata, and H Yoshimi, and F Marumo, and T X Watanabe, and S Kumagaye, and K Nakajima, and T Kimura, and S Sakakibara
January 1989, Biochemical and biophysical research communications,
Y Hirata, and H Yoshimi, and F Marumo, and T X Watanabe, and S Kumagaye, and K Nakajima, and T Kimura, and S Sakakibara
January 1992, Glia,
Y Hirata, and H Yoshimi, and F Marumo, and T X Watanabe, and S Kumagaye, and K Nakajima, and T Kimura, and S Sakakibara
January 1992, Life sciences,
Y Hirata, and H Yoshimi, and F Marumo, and T X Watanabe, and S Kumagaye, and K Nakajima, and T Kimura, and S Sakakibara
January 1991, Neurochemistry international,
Y Hirata, and H Yoshimi, and F Marumo, and T X Watanabe, and S Kumagaye, and K Nakajima, and T Kimura, and S Sakakibara
August 1993, European journal of pharmacology,
Copied contents to your clipboard!